The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Gyenes Lawrence A since 2005.
The trader's CIK number is 1301629.
At the time of the last reporting, Gyenes Lawrence A was the SVP, Chief Financial of Juniper Pharmaceuticals Inc. (stock ticker symbol JNP).
Also see all insider trading activities at Juniper Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2009 | CBRX | 50,000 | $43,300 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2005 | SVNT | 15,000 | $46,125 | 0 | $0 | 0 | $0 |
1. Juniper Pharmaceuticals Inc (CBRX)
2. Savient Pharmaceuticals Inc (SVNT)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-11-09 | CBRX | Buy | 50,000 | .87 | 43,300 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2005-05-17 | SVNT | Buy | 15,000 | 3.08 | 46,125 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gyenes Lawrence A (SVP, Chief Financial of Juniper Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.